Skip to main content
Clinical Trials/KCT0005685
KCT0005685
Recruiting
N/A

sefulness of contrast-enhanced ultrasound (CEUS) in Crohn’s disease pediatric patients

Overview

Phase
N/A
Intervention
Not specified
Conditions
Diseases of the digestive system
Sponsor
Yonsei University Health System, Severance Hospital
Enrollment
20
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients who are under the age of 18 with Crohn’s disease with colonoscopy within 2 years of IRB approval

Exclusion Criteria

  • Patients who are over the age of 18 and under the age of two
  • \- Patients who did not under go colonoscopy
  • \- Patients who have other bowel disease or mass than Crohn’s disease
  • \- High allergic sensitivity to Sonovue injection agent or sulfur hexafluoride
  • \- Patients who have right to left shunt, pulmonary hypertension, or systemic hypertension
  • \- Patients who have end stage renal or liver disease or septic shock

Outcomes

Primary Outcomes

Not specified

Similar Trials